Medicine and Dentistry
Acute Graft Versus Host Disease
11%
Acute Leukemia
16%
Acute Lymphoblastic Leukemia
14%
Acute Myelogenous Leukemia
12%
Acute Myeloid Leukemia
29%
Acute Promyelocytic Leukemia
11%
Age
10%
Allogeneic Hematopoietic Stem Cell Transplantation
14%
Allogeneic Stem Cell Transplantation
16%
Blood
9%
Busulfan
11%
Cell Transplantation
11%
Cells
10%
Chronic Graft Versus Host Disease
9%
Chronic Myelogenous Leukemia
9%
Combination Therapy
18%
Complication
8%
Conditioning
9%
Cyclophosphamide
12%
Diseases
10%
Donor
23%
Experience
9%
Fludarabine
14%
Follow up
10%
Graft Versus Host Reaction
14%
Graft Versus Host Reaction
10%
Hematopoietic Cell
13%
Hematopoietic Stem Cell Transplantation
18%
Hepatitis B Virus
9%
Incidence
9%
Infection
18%
Inpatient
32%
Mortality
11%
Multivariate Analysis
8%
Myelodysplastic Syndrome
13%
Myelofibrosis
13%
Neoplasm
11%
Overall Survival
14%
Patient
100%
Photopheresis
10%
Platelet
8%
Retrospective Study
9%
Spontaneous Remission
12%
Stem Cell Therapy
13%
Stem Cell Transplant
10%
T Cell
8%
Therapeutic Procedure
21%
Thiotepa
9%
Transplantation
34%
Virus Reactivation
9%
Immunology and Microbiology
Acute Graft Versus Host Disease
6%
Allogeneic Stem Cell Transplantation
8%
Cell Transplantation
9%
Cells
5%
Chimeric Antigen Receptor T-Cell
5%
Chimeric Antigen Receptor T-Cell Therapy
7%
Conditioning
9%
Cyclophosphamide
5%
Graft-Versus-Host Disease
16%
Hematopoietic Cell
7%
Hematopoietic Stem Cell Transplantation
10%
Mortality
5%
Myeloid
15%
Overall Survival
10%
Transplantation
18%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
5%
Acute Myeloid Leukemia
7%
Alkylating Agent
5%
Busulfan
14%
Complication
5%
Cyclophosphamide
8%
Fludarabine
5%
Graft Versus Host Reaction
5%
Hepatitis B Virus
5%
Infection
7%
Leukemia
6%
Myelodysplastic Syndrome
7%
